| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/03/2004 | WO2004046174A2 A method of obtaining new somatostatin analogues |
| 06/03/2004 | WO2004046171A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004046169A2 Activation of peptide prodrugs by hk2 |
| 06/03/2004 | WO2004046168A2 Recombinant hiv-1 subclass d envelope glycoproteins |
| 06/03/2004 | WO2004046166A2 Modified alpha-msh peptides and derivatives thereof |
| 06/03/2004 | WO2004045648A1 Positional isomers of peg ifn alpha 2a |
| 06/03/2004 | WO2004045640A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | WO2004045639A1 Live attenuated vaccine against porcine pleuropneumonia |
| 06/03/2004 | WO2004045638A1 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 06/03/2004 | WO2004045558A2 Compositions and methods for treating thrombotic disorders |
| 06/03/2004 | WO2004045555A2 Immunogenic epitopes for fibroblast growth factor 5 (fgf-5) presented by hla-a3 and hla-a2 |
| 06/03/2004 | WO2004045553A2 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 06/03/2004 | WO2004045548A2 Genetic constructs and compositions comprising rre and cte and uses thereof |
| 06/03/2004 | WO2004045544A2 Autocrine growth factor receptor antibodies and methods |
| 06/03/2004 | WO2004045540A2 Method for continuous, automated blending of solutions from acids and bases |
| 06/03/2004 | WO2004045535A2 Molecular interactions in neurons |
| 06/03/2004 | WO2004045529A2 West nile virus vaccine |
| 06/03/2004 | WO2004045520A2 Complement receptor 2 targeted complement modulators |
| 06/03/2004 | WO2004045519A2 Induction of apoptosis by hiv-1 infected monocytic cells |
| 06/03/2004 | WO2004045499A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 06/03/2004 | WO2004045495A2 Interacting site for gp41 on gp120 of hiv-1 |
| 06/03/2004 | WO2004045379A2 Biomarkers for intra-amniotic inflammation |
| 06/03/2004 | WO2004045369A2 Nuclear receptor-based diagnostic, therapeutic, and screening methods |
| 06/03/2004 | WO2004035623A3 Stabilized exendin-4 compounds |
| 06/03/2004 | WO2004035615A3 Factor involved in metastasis and uses thereof |
| 06/03/2004 | WO2004033723A3 Neurodegenerative disease-associated gene |
| 06/03/2004 | WO2004028562A3 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 06/03/2004 | WO2004027033A3 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/03/2004 | WO2004026903A3 Live antenuated parasite vaccine |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004024769A3 Ostertagia vaccine |
| 06/03/2004 | WO2004024084A9 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 06/03/2004 | WO2004022708A3 Genes and proteins altering tau-related neurodegeneration |
| 06/03/2004 | WO2004022103A3 Foxp1 and uses thereof |
| 06/03/2004 | WO2004021781A3 Cryptophlebia leucotreta granulovirus (crlegv-sa) as a biological control agent |
| 06/03/2004 | WO2004018696A3 Method for determining the allelic state of the 5'-end of the $g(a)s1-casein gene |
| 06/03/2004 | WO2004018638A3 Iron transport and metabolism proteins |
| 06/03/2004 | WO2004018515A3 T-cell epitopes in erythropoietin |
| 06/03/2004 | WO2004016283A3 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 06/03/2004 | WO2004013306A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 06/03/2004 | WO2004011648A3 CYTOCHROME P450s |
| 06/03/2004 | WO2004011488A9 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 06/03/2004 | WO2004009021A3 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/03/2004 | WO2004007725A9 Polypeptide of streptococcus pyogenes |
| 06/03/2004 | WO2004007663A9 Gene expression using metal ion dependent repressor/operator tandems |
| 06/03/2004 | WO2004005502A9 Programmed cell death used as a biological containment system |
| 06/03/2004 | WO2004002513A3 Proteins involved in the regulation of energy homeostasis |
| 06/03/2004 | WO2004002415A9 Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
| 06/03/2004 | WO2003103697A3 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity |
| 06/03/2004 | WO2003103595A3 Androgen receptor coregulators |
| 06/03/2004 | WO2003100432A3 Method for identifying immunoreactive peptides |
| 06/03/2004 | WO2003096022A8 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 06/03/2004 | WO2003095493A3 Toxin-related antibodies with antimicrobial and antiviral activity |
| 06/03/2004 | WO2003093787A3 Antiproliferative protein from hypericum perforatum and nucleic acids encoding the same |
| 06/03/2004 | WO2003093476A9 Vector with modified protease-dependent tropism |
| 06/03/2004 | WO2003091275A3 Compositions containing anti-hiv peptides and methods of use |
| 06/03/2004 | WO2003089580A3 Cancer models |
| 06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | WO2003079025A3 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 06/03/2004 | WO2003062415A3 Transgenic animal comprising intracellular immunoglobins for xenotransplantation |
| 06/03/2004 | WO2003061680A9 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease |
| 06/03/2004 | WO2003051310A3 Methods of inhibiting fertility |
| 06/03/2004 | WO2003040292A3 Genes encoding for membrane synthesis and membrane transport proteins |
| 06/03/2004 | WO2003037930A8 Novel human n-methyl-d-asparatate (nmda) glutamate receptor polypeptide and gene encoding the same |
| 06/03/2004 | WO2003024481A3 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/03/2004 | WO2003018610A8 Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods |
| 06/03/2004 | WO2003000928A3 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO2002093998A3 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 06/03/2004 | WO2002088312A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 06/03/2004 | WO2002079402A9 Method of inhibiting cancerous cell proliferation using ras mutants of gdp-bound conformation |
| 06/03/2004 | WO2002064739A3 A cytokine related structurally to il-17 |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040107463 Transcription factor stress-related proteins and methods of use in plants |
| 06/03/2004 | US20040107458 Gene encoding plant protein tm2a, conferring resistance to tomato mosaic virus |
| 06/03/2004 | US20040107456 Transcription factors for rice or barley cells used to produce antibodies; genetic engineering |
| 06/03/2004 | US20040107455 genetically enhancing the nutritional value/agronomic performance without permanent or stable incorporation of unknown/foreign DNA into plant genome |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106784 Comprises nucleotide sequences coding negative regulators of cytokine signal transduction for use in screening modulators for treatment of diabetes, inflammation, metabolic and cancer disorders |
| 06/03/2004 | US20040106783 DNA fragments of the methylotrophic Pichia pastoris yeast ICL gene |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106777 Comprises nucleotide sequences coding extracelular matrix interacting protein for screening and identifying modulators and treatment for cancers and arteriosclerosis; tissue engineering |
| 06/03/2004 | US20040106776 Methods of crystal optimisation |
| 06/03/2004 | US20040106775 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/03/2004 | US20040106773 Human tuberoinfundibular peptide of 39 residues |
| 06/03/2004 | US20040106772 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 06/03/2004 | US20040106571 modulator of tumor growth and metastasis in certain cancer types, especially breast and lung cancer |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 06/03/2004 | US20040106564 Use of slpi for treating chronic inflammatory intestinal diseases |
| 06/03/2004 | US20040106555 Neurogenin3 and production of pancreatic islet cells |
| 06/03/2004 | US20040106554 polypeptide analogs of myelin basic protein for treatment of multiple sclerosis |
| 06/03/2004 | US20040106552 amyloid precursor proteins; for use in treatment of Alzheimer's disease/neurodegenerative diseases and as cognitive enhancers |
| 06/03/2004 | US20040106551 Human papilloma virus immunoreactive peptides |
| 06/03/2004 | US20040106550 comprises chondromodulin-1 protein which grows articular chondrocytes by itself or under coexistence with fibroblast growth factor, and is capable of suppressing hyper degradation of cartilage matrix; gene therapy |
| 06/03/2004 | US20040106549 Anti-angiogenic proteins and methods of use thereof |
| 06/03/2004 | US20040106548 amide cyclization; for altering stability and specificity of receptor-targeted agents |
| 06/03/2004 | US20040106547 glucose lowering protein (GLP-1); exendins; for regulation of excess levels of blood glucose and/or regulation of gastric emptying; for treatment of diabetes and eating disorders |